J2KBIO Future Growth

Future criteria checks 2/6

J2KBIO is forecast to grow revenue at 38.3% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth72.9%
Revenue growth rate38.3%
Future return on equityn/a
Analyst coverage

Low

Last updated28 Aug 2024

Recent future growth updates

No updates

Recent updates

J2KBIO (KOSDAQ:420570) Has A Rock Solid Balance Sheet

Aug 23
J2KBIO (KOSDAQ:420570) Has A Rock Solid Balance Sheet

Earnings and Revenue Growth Forecasts

KOSDAQ:A420570 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202560,500N/AN/AN/A1
12/31/202448,100N/AN/AN/A1
9/30/202434,706-656-1,2456,234N/A
6/30/202435,9221,009-2844,163N/A
3/31/202430,848-3121,7743,839N/A
12/31/202328,4724,8441,6983,285N/A
9/30/202324,4734,1652,3973,222N/A
6/30/202321,0883,3562,5342,733N/A
3/31/202317,7912,5011,5201,662N/A
12/31/202216,0322,0861,2681,448N/A
12/31/202114,2191,6231,1862,001N/A
12/31/202013,8581,475-1,159852N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A420570's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A420570's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A420570's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: A420570's revenue (38.3% per year) is forecast to grow faster than the KR market (9.4% per year).

High Growth Revenue: A420570's revenue (38.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A420570's Return on Equity is forecast to be high in 3 years time


Discover growth companies